PTC Appoints James A. Lico to Board of Directors

PTC (NASDAQ: PTC) today announced that it has appointed James (Jim) Lico to its Board of Directors, effective October 13, 2025.

Lico is the former President and Chief Executive Officer of Fortive Corporation, a provider of safety and productivity solutions to industrial and healthcare markets. During his tenure as President and CEO, Lico led Fortive's transformation following its 2016 separation from Danaher Corporation, building a focused portfolio that grew annual revenue to more than $6 billion and overseeing the separation of its Precision Technologies segment into the independent company Ralliant. He is currently on the Board of Directors of DuPont de Nemours, Inc., serving on the People and Compensation Committee and the Environment, Health, Safety & Sustainability Committee.

"Jim brings decades of experience running global businesses and working closely with customers to transform their operations," said Neil Barua, President and CEO, PTC. "His leadership, deep understanding of industrial technology, and proven ability to drive growth make him a valuable addition to our Board as we continue our efforts to grow our business and support our customers."

"I've spent my career helping technology companies evolve and grow, and PTC is doing exactly that – driving transformation for manufacturers and product companies with its Intelligent Product Lifecycle vision," said Lico. "I'm thrilled to join the PTC Board and look forward to applying my experience as we work to create shareholder value."

Prior to serving as President and CEO of Fortive Corporation, Lico spent nearly two decades at Danaher in senior leadership roles, where he led a broad set of global businesses across test and measurement and industrial technologies. Earlier in his career, he held management positions at AlliedSignal and General Motors.

Lico will serve on the PTC Board's Corporate Governance Committee.

About PTC

PTC (NASDAQ: PTC) is a global software company that enables industrial and manufacturing companies to digitally transform how they design, manufacture, and service the physical products the world relies on. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, please visit www.ptc.com.

Media 

Greg Payne

gpayne@ptc.com 

Investors

Matt Shimao

mshimao@ptc.com 

PTC and the PTC logo are trademarks or registered trademarks of PTC Inc. and its subsidiaries in the United States and other countries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-appoints-james-a-lico-to-board-of-directors-302581525.html

SOURCE PTC Inc.

News Provided by PR Newswire via QuoteMedia

PTC
The Conversation (0)
Stock Trend Capital

Stock Trend Capital Announces Loan to eGOD Digital Labs for Dogecoin Mining

Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (PTC Pink: STOCF) (the "Company" or "Stock Trend") announces that the Company has entered into a loan agreement (the "Loan Agreement") dated January 7, 2025, with 1001070426 Ontario Inc. dba eGOD Digital Labs ("eGod" or "the "Borrower"), whereby... Keep Reading...
Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy  Achieved or Maintained the Ability to Sit, Stand or Walk

Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy Achieved or Maintained the Ability to Sit, Stand or Walk

- After 5 years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past 2 years of age - - 96% of Evrysdi-treated children could swallow, 80% could feed without a feeding tube and 59% could sit without support for at least 30... Keep Reading...
Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

News Summary: The new solution will combine Cisco and NVIDIA innovation to simplify the deployment of generative AI applications, providing IT visibility and analytics across the entire AI infrastructure stack. Cisco Nexus HyperFabric AI clusters make it easy for enterprise customers to build... Keep Reading...
Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

(TheNewswire) Brossard, Quebec, MAY 14, 2024 TheNewswire - Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the "Company" or "CHARBONE"), North America's only publicly traded pure-play green hydrogen company, today announced that the Company has received a US$60.8 Million... Keep Reading...
"investingnews.com"

Northstar Applies to Cross Trade on the OTCQB Venture Market in the US

Northstar Clean Technologies Inc. (TSXV: ROOF) ("Northstar" or the "Company") announces that it has filed its application for its common shares to be cross traded on the OTCQB Venture Market (the "OTCQB"). The OTCQB market provides a platform for a wide variety of companies to be able to trade... Keep Reading...
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News